Cargando…
Immunologic aspect of ovarian cancer and p53 as tumor antigen
Ovarian cancer represents the fifth leading cause of death from all cancers for women. During the last decades overall survival has improved due to the use of new chemotherapy schedules. Still, the majority of patients die of this disease. Research reveals that ovarian cancer patients exhibit signif...
Autores principales: | Nijman, HW, Lambeck, A, van der Burg, SH, van der Zee, AGJ, Daemen, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1243238/ https://www.ncbi.nlm.nih.gov/pubmed/16164749 http://dx.doi.org/10.1186/1479-5876-3-34 |
Ejemplares similares
-
Immunological and Clinical Effects of Vaccines Targeting p53-Overexpressing Malignancies
por: Vermeij, R., et al.
Publicado: (2011) -
Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer
por: Vermeij, Renee, et al.
Publicado: (2010) -
Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer
por: Wouters, MCA, et al.
Publicado: (2015) -
A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer
por: Dijkgraaf, Eveline M., et al.
Publicado: (2015) -
Application of sentinel nodes in gynaecological cancer therapy
por: Oonk, M.H.M., et al.
Publicado: (2013)